Non-QM Mortgage Lenders in Boston, MA

The Boston Non-QM Landscape in 2026

Boston remains one of the most supply-constrained housing markets in the country. The median single-family price hovers near $857,000 as of early 2026, up roughly 1–2% year over year, while Greater Boston overall averages around $780,000 — down slightly from 2025 peaks as inventory ticked up 4.3% but still among the most expensive metros outside coastal California. Homes sell in 20–33 days for well-priced listings; hot properties in Brookline, Newton, and Cambridge still go to multiple offers inside 10 days. Inventory sits under 1.5 months of supply metro-wide — effectively no slack in the system.

Boston's Non-QM market is defined by its dual economic engines: biotech and financial services. The Route 128 biotech corridor — Moderna, Biogen, Vertex Pharmaceuticals, and hundreds of smaller CRO and life science companies — generates thousands of employees with compensation heavy in stock options, milestone bonuses, and consulting arrangements. A principal scientist who earns $250,000 in base and $180,000 in options and bonuses in year one of a new role looks very different on a tax return than their actual economic position. Bank statement loans and asset depletion programs capture that reality.

Neighborhoods Driving Non-QM Demand

• South End: Boston's densest self-employed owner-occupant market — restaurant owners, design firm principals, boutique business operators, and creative professionals buying $700,000–$1.2M condos and townhouses. Bank statement loans are the primary program; conforming loan limits are largely irrelevant at these price points anyway.
• Dorchester / Jamaica Plain: The metro's most active multifamily investment corridor. Three-deckers at $700,000–$950,000 with all three units rented produce cap rates that support DSCR financing. Investors buying Boston multifamily hold LLCs and qualify on combined rental income rather than personal income documentation.
• Cambridge / Somerville: Tech and biotech employee concentration — MIT-adjacent professionals, startup founders, and VC-backed company executives who earn through equity and carry income documentation complexity. Asset depletion programs and bank statement loans both have significant application in this corridor. Purchase prices $900,000–$1.6M+.
• Brookline / Newton: Premium western suburbs at $950,000–$1.8M for single-family homes. High concentration of physicians from Brigham and Women's, Beth Israel, and Mass General who have student debt ratios that break conventional math. Physician programs serve this population; asset depletion loans serve the established medical professional buying at the higher end.
• East Boston / Chelsea: Emerging value-add investment corridor with multifamily properties at $550,000–$850,000. Fix-and-flip bridge financing funds investors repositioning older three-family stock. Appreciation trajectory in East Boston — driven by the Silver Line extension and Logan proximity — supports the renovation math.
• Quincy / Braintree: South Shore suburbs at $550,000–$750,000 where Boston commuters buy. Strong 1099 and contractor workforce from financial services firms in the Financial District; these workers commute from the south shore and need bank statement programs when their compensation is bonus-heavy.

Who's Actually Borrowing Non-QM in Boston

Boston's Non-QM volume is disproportionately driven by two profiles. First: the biotech and pharmaceutical professional — a scientist, clinical researcher, or executive who receives significant equity compensation and whose tax returns in a vesting year look completely different from non-vesting years. Conventional underwriters who average two years of W-2 income often penalize the borrower in the non-vesting year. Bank statement programs or asset depletion using vested equity positions are the right tools here.

Second: Massachusetts physicians — a population that concentrates heavily in Boston's hospital network (the Boston Teaching Hospitals: MGH, Brigham, BIDMC, Tufts) and carries, on average, some of the highest student debt loads in the country. A graduating MGH hospitalist with $420,000 in student debt and a $310,000 attending salary cannot get through conventional DTI calculations without a physician program that defers or excludes IBR student loan payments from the ratio. This profile drives significant Boston Non-QM volume.

Best-Fit Program by Scenario

• Cambridge biotech founder buying a $1.1M condo: Seed-stage company, taking $120,000 W-2 salary, holds $2.4M in vested stock options. No current income to support the purchase on a conventional basis. Solution: asset depletion loan using the vested equity position. The $2.4M divided over standard depletion methodology generates qualifying monthly income that supports the purchase.
• South End restaurant owner buying a $875,000 townhouse: Multi-location food and beverage operation, $1.1M annual revenue, $72,000 personal taxable income. Solution: 24-month business bank statement loan. Monthly deposits average $88,000–$95,000. After expense factor, qualifying income well above purchase requirement.
• Dorchester three-decker investor acquiring a $820,000 property: All three units rented at $2,400–$2,600/unit, $7,400/month combined gross. DSCR at 1.15+ at current rates with 25% down. Solution: DSCR loan in LLC. No personal income review. Close in 3 weeks rather than 45 days on conventional.
• Brigham physician buying a $950,000 home in Brookline: $340,000 attending salary, $380,000 in student loans. Solution: physician program with IBR exclusion or deferred student loan treatment. No PMI, qualifies on full attending income without the student debt torpedo to the DTI ratio.

Why NonQM.loan for Boston Borrowers

Boston's lender market is sophisticated but conventional-heavy. The city's major banks and mortgage companies are calibrated for the W-2 professional purchase that dominates Greater Boston volume. Biotech equity compensation and physician student debt are genuinely underserved — borrowers who get bounced by three conventional lenders before finding a Non-QM specialist is a common Boston story. NonQM.loan maintains relationships with lenders who have active Massachusetts programs and who understand how to document equity comp, handle DSCR multifamily in a high-value market, and structure physician loans for MGH and Brigham attendings. The lender intelligence — knowing which lenders are pricing well for each profile right now — is the value delivered here.